Posted on 2/1/21
SWORD Health Raises $25 Million in Series B
SWORD Health, the world’s fastest growing virtual musculoskeletal (MSK) care provider, has raised a $25 million financing round, bringing SWORD’s cumulative fundraising to $50 million.
Posted on 2/1/21
TechFW Client Nanoscope on Winning Team in National Eye Institute Challenge
With the eyes of the nation upon them, leading ophthalmic researchers at the University of Colorado, Miami University and those from Nanoscope® , led by Samarendra . . .
Posted on 2/1/21
ADMA Biologics Receives FDA Approval for ADMA BioCenters Plasma Collection Facility in Knoxville, TN
RAMSEY, N.J. and BOCA RATON, Fla. and KNOXVILLE, Tenn., Feb. 01, 2021 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA”), an end-to-end commercial biopharmaceutical company . . .
Posted on 2/1/21
BWXT Names Nuclear Medicine Business as BWXT Medical
LYNCHBURG, Va.--(BUSINESS WIRE)--BWX Technologies, Inc. (NYSE: BWXT) today announced that its subsidiary BWXT ITG Canada, Inc., a nuclear medicine company, has been renamed BWXT Medical Ltd. . . .
Posted on 2/1/21
Sensei Biotherapeutics Launch of IPO
BOSTON & ROCKVILLE, Md.--(BUSINESS WIRE)--Sensei Biotherapeutics, Inc., a clinical-stage immunotherapy company focused on the discovery and development of next generation therapeutics for cancer, today announced that . . .
Posted on 2/1/21
Horizon Therapeutics To Acquire Viela Bio
Horizon Therapeutics plc (Nasdaq: HZNP) and Viela Bio, Inc. (Nasdaq: VIE) today announced the companies have entered into a definitive agreement under which
Posted on 2/1/21
Novavax Executives Sold $46 Million Worth of Stocks Amid 2,731% Gains in 2020
US pharmaceutical company Novavax saw its stock hit various highs in 2020 as vaccine trials progressed. According to the research data analyzed and published by Stock . . .
Posted on 2/1/21
Look Out, Pfizer and Moderna: Here Comes Novavax
Over the last couple of months, COVID-19 vaccines developed by Moderna (NASDAQ:MRNA) and Pfizer (NYSE:PFE) along with its partner BioNTech (NASDAQ:BNTX) have been at the center . . .
Posted on 2/1/21
Better Coronavirus Stock: Johnson & Johnson vs. Pfizer
Pharmaceutical companies Pfizer (NYSE:PFE) and Johnson & Johnson (NYSE:JNJ) are two of the biggest players in the race to vaccinate the world against COVID-19. Pfizer's vaccine, . . .
Posted on 2/1/21
Can Moderna and Pfizer Meet President Biden's Vaccine Goals?
If the goal of President Joe Biden is met, at least 100 million doses of vaccine will be delivered into people's arms by his 100th day . . .
Posted on 2/1/21
Johnson & Johnson Says Its One-Dose Coronavirus Vaccine Was 66% Effective in Clinical Trial
Johnson & Johnson (NYSE:JNJ) released results today from the phase 3 clinical trial of its COVID-19 vaccine candidate, saying that the data showed it was 66% . . .
Posted on 2/1/21
Is Novavax Stock a Buy?
With a mouth-watering return of 1,770% in the past year, Novavax (NASDAQ:NVAX) is undoubtedly the best-performing coronavirus stock on the market. The company total return growth . . .
Posted on 2/1/21
Which Is the Best COVID Vaccine Stock: Pfizer, BioNTech, Moderna, Johnson & Johnson, or Novavax?
Which COVID-19 vaccine is the best? The correct answer is that it depends on which factor is most important to you.Comirnaty (BNT162b2), the vaccine developed by . . .
Posted on 2/1/21
Look Out, Pfizer and Moderna: Here Comes Novavax
Over the last couple of months, COVID-19 vaccines developed by Moderna (NASDAQ:MRNA) and Pfizer (NYSE:PFE) along with its partner BioNTech (NASDAQ:BNTX) have been at the center . . .
Posted on 2/1/21
Yield10 Bioscience Prices of $12.7 Million Public Offering
WOBURN, Mass., Jan. 31, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, today announced the pricing of its underwritten public offering . . .
Posted on 1/31/21
Maryland’s COVID-19 Hospitalizations Continue to Decrease but Remain Higher than Most of Pandemic
The number of Marylanders currently hospitalized with coronavirus decreased to 1,616 on Friday, state data show.Other than a slight increase on Wednesday, Maryland’s COVID-19 hospitalizations have . . .
Posted on 1/30/21
CA Healthcare Acquisition Corp. Closes $115M IPO
BOSTON--(BUSINESS WIRE)--CA Healthcare Acquisition Corp. announced today the completion of its initial public offering of 11,500,000 units, including 1,500,000 units issued pursuant to the full exercise by . . .
Posted on 1/30/21
Scopus BioPharma Closes $9M Follow-On Public Offering
Scopus BioPharma Inc. (Nasdaq: SCPS) today announced the closing of a $9 million follow-on public offering. The offering consisted of 1,000,000 shares of common stock at . . .
Posted on 1/30/21
Bioasis Announces $200,000 Non-Brokered Private Placement
GUILFORD, Conn., Jan. 29, 2021 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3 ™ platform technology for . . .
Posted on 1/30/21
Peak Physical Therapy & Sports Performance Staff Received First Dose of COVID-19 Vaccines on January 26th
Director of Operations Shannon Delaney and Owner Eric Edelman after receiving their vaccinesPeak Physical Therapy & Sports Performance, a South Shore practice specializing in unique programs . . .
Posted on 1/30/21
Maryland Patient Safety Center Offers Ideas to Increase COVID-19 Vaccine Acceptance Among Frontline Caregivers
Ongoing Series of Online Seminars in Partnership with the Maryland Hospital Association Features National Expert Nicole T. Rochester, MD The Maryland Patient Safety Center (MPSC), the . . .
Posted on 1/29/21
Moleculin Announces Reverse Stock Split
Moleculin Biotech, Inc., (Nasdaq: MBRX), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and viruses, today announced that . . .
Posted on 1/29/21
Thermo Fisher Scientific Named "Best Place to Work for LGBTQ Equality" for Sixth Consecutive Year
Thermo Fisher Scientific Inc., (NYSE:TMO), the world leader in serving science, was recognized as a "Best Place to Work for LGBTQ Equality" for the sixth consecutive . . .
Posted on 1/29/21
EQ Health Acquisition Corp. Prices of Upsized $191.1 Million IPO
AUSTIN, Texas--(BUSINESS WIRE)--EQ Health Acquisition Corp., today announced the pricing of its initial public offering of 19,130,400 units at a price of $10.00 per unit. The . . .
Posted on 1/29/21
Catabasis Pharmaceuticals Acquires Quellis Biosciences
Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a biopharmaceutical company, today announced that it has acquired Quellis Biosciences Inc., a privately-held emerging biopharmaceutical
